Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004525233 | SCV005034331 | pathogenic | Hereditary cancer-predisposing syndrome | 2023-10-13 | criteria provided, single submitter | clinical testing | The c.569dupC pathogenic mutation, located in coding exon 6 of the PTEN gene, results from a duplication of C at nucleotide position 569, causing a translational frameshift with a predicted alternate stop codon (p.V191Sfs*11). This alteration was identified in a family with features consistent with PTEN-related disease (Sherman SK et al. Cancer Genet, 2015 Nov;208:41-6). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |